Eur Rev Med Pharmacol Sci 2021; 25 (19): 5922-5927
DOI: 10.26355/eurrev_202110_26868

A case of chronic systemic capillary leak syndrome (SCLS) exacerbated during SARS-CoV2 infection

A. Concistrè, F. Alessandri, E. Rosato, F. Pugliese, M. Muscaritoli, C. Letizia

Department of Translational and Precision Medicine, University “Sapienza”, Rome, Italy. claudio.letizia@uniroma1.it

Systemic capillary leak syndrome (SCLS) is a very rare and lethal disease characterized by hemoconcentration and hypoalbuminemia caused by reversible plasma extravasation. The underlying cause for SCLS remains largely unknown and acute treatment has remained mainly supportive. Prophylaxis with intravenous immunoglobulin (IVIG) has been shown to successfully prevent further episodes in affected patients. We reported a case of SCLS in a patient who presented to our hospital with COVID-19 and developed profound shock.

Free PDF Download

To cite this article

A. Concistrè, F. Alessandri, E. Rosato, F. Pugliese, M. Muscaritoli, C. Letizia
A case of chronic systemic capillary leak syndrome (SCLS) exacerbated during SARS-CoV2 infection

Eur Rev Med Pharmacol Sci
Year: 2021
Vol. 25 - N. 19
Pages: 5922-5927
DOI: 10.26355/eurrev_202110_26868

Keywords Related articles:

  1. The first case of systemic lupus erythematosus (SLE) triggered by COVID-19 infection
  2. SARS-CoV-2 systemic infection in a kidney transplant recipient: sequence analysis in clinical specimens
  3. Case report of COVID-19 in an elderly patient: could SARS-CoV2 trigger myositis?
  4. Neurological, otolaryngological and ophthalmological implications of Susac syndrome – a case report
  5. Editorial – Sofosbuvir/Velpatasvir as a combination with strong potential activity against SARS-CoV2 (COVID-19) infection: how to use direct-acting antivirals as broad-spectrum antiviral agents